Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Ltd, an ASX-listed biotech firm, is set to present at the ShareCafe Small Cap ‘Hidden Gems’ Webinar, highlighting their advancements in iNKT cell therapy for cancer treatment. The company is pioneering ALA-101, a CAR19-iNKT cell-based therapy targeting CD19 antigens on cancer cells, and is expanding into solid tumor treatments through new licensed technologies. Interested parties can register for the no-cost webinar, with a recorded version available post-event.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
